Danaher’s Cepheid gets first WHO prequalification nod for TB tests
Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests.
The UK, along with a clutch of government and private entities, has set afoot plans to create the worldâs first real-time surveillance system.
HQ Team May 17, 2024: A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely.
HQ Team April 15,2024:Adding to the climate change worries is the fear Vibrio vulnificus, commonly known as flesh-eating bacteria, is expanding its territory.
HQ Team January 5, 2023: Moderna Inc., expects to break even in 2026 as it aims to drive profits by âdisciplined investmentâ and.
HQ Team January 1, 2024: As the conflict in Gaza rages on, a dual crisis emerges, with infectious diseases and hunger posing severe.
By K. Leelamoni November 5, 2023: Outbreaks of pneumonia affecting children in parts of northern China, the US, the Netherlands, and Denmark are higher than.
HQ Team May 3, 2023: First major signs of health system recovery, after three years of the COVID-19 pandemic, were visible at the.
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.